Helps pharmaceutical and biotech clients identify strategic and operational opportunities for growth and innovation and supports them through transformation and change

About Martin

Martin Møller co-leads our work on R&D with pharmaceuticals and medical products companies in Europe, the Middle East, and Asia. He has extensive experience across R&D, operations, and marketing.

Recent project highlights include the creation of global launch plans that addressed supply, regulatory, and commercial issues for a primary-care blockbuster; support to a global R&D strategy and transformation program for a major pharma company; identification of strategic and operational opportunities in a small-molecule-focused R&D organization; development of a research strategy to help a client enter selected new disease areas; and the design of a new approach to cross-functional management of R&D projects.

Published work

Trends in clinical success rates,” Nature Reviews Drug Discovery, May 2016

Improving R&D productivity,” Nature Reviews Drug Discovery, June 2015

Outlook for the next 5 years in drug innovation,” Nature Reviews Drug Discovery, June 2012

Escaping the sword of Damocles: Toward a new future for pharmaceutical R&D,” (PDF–1.76 MB), McKinsey, 2012


University of Copenhagen
MA in comparative literature